Dan Neylan

Dan Neylan is an experienced finance professional currently serving as the Director of Financial Modeling at Prime Therapeutics since June 2022. Prior to this role, Dan held various positions at Magellan Health from March 2017 to June 2022, including Senior Manager and Manager in Underwriting, Analytics, and Reporting. Dan's earlier experience includes working as an FP&A Manager at NRG Home Solar, where significant transitions to a new business model were managed, achieving cost savings and revenue enhancements. Additionally, Dan contributed to the healthcare sector at The Buonopane Group as a Project Manager and Pricing Analyst, developing market-based pricing models and conducting comprehensive reviews of contracts. Dan's career began as an Analyst at Sterling Grace Municipal Securities, focusing on bond research and pricing. Dan holds a Bachelor of Science degree in Economics from Boston University.